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Investigation of the lipid constituents of the aerial parts of Phyllanthus atropurpureus resulted in 
isolation and identification of the fatty acid mixture which consists of eight acids with linolenic acid as 
major and the unsaponifiable fraction that contain a series of hydrocabons, sterols, in addition to one 
triterpene (α-amyrin). The acetone insoluble fraction was found to contain two fatty alcohols and three 
n-hydrocabons in which the n-eicosane is the most abundant (44.16%). The flavonoidal constituents 
were isolated from ethyl acetate and butanol fractions which were identified as: luteolin-7-O-glucoside, 
kaempferol 3-O-(p-coumaroylglucoside), kaempferitrin, luteolin and kaempferol. Evaluation of different 
extracts as acetylcholinesterase inhibitors (AChI), established the chloroform fraction as a promising 
inhibitor of the enzyme. The antioxidant testing with DPPH radical revealed the potential of precipitate 
from MeOH extract as a radical scavenger. 
Keywords: Phyllanthus atropurpureus. Euphorbiaceae. Flavonoids. Acetylcholineesterase inhibitors. 
Antioxidant. 
INTRODUCTION
Phyllanthus (Euphorbiaceae) is a large genus and 
widely distributed in tropical and subtropical zones 
like tropical Africa, tropical America and Asia. This 
genus, consisting of more than 700 species. It has been 
employed as herbal drugs for a long time in China, 
India, Brazil and Southeast Asian countries. The most 
abundant species are used and have a beneficial role for 
the treatment of digestive, genitourinary, respiratory, 
skin diseases, antioxidant, antihepatotoxic, anticancer, 
antidiabetic, diuretic, anti-inflammatory to treat hepatitis 
B, hypertension, dropsy, sore throat, to cure jaundice, renal 
calculus and malaria (Mao et al., 2016). Also, P. niruri 
contain many phytochemical constituents like alkaloids, 
anthocyanins, flavonoids, phenolic acids, lignans and 
saponins. Combined saponin and alkaloid of the plant 
showed more potency and may offer an alternative 
therapeutic agent against bacterial infections (Ajibade, 
2014; Kaur, Kaur, Sirhindi, 2017).
The chemical review on genus Phyllanthus, 
revealed the presence of sterols, and/ or terpenes, 
flavonoids (5,6,8,4´-tetrahydroxy isoflavone, robustaside 
A and 6´-(3″,4″- dihydroxycinnamoyl), arbutin, 
demethoxysudachitin, polyphenolic compounds and 
tannins, in addition to minor alkaloids (EL-Saywd, 2009; 
Sarg et al., 2012).
Alzheimer’s disease (AD) is the most common form 
of dementia and accounts for approximately 60% of all 
dementia cases. Till now there is no discovered medication 
that can slow or stop the neurodegeneration process of AD, 
where current treatment medicines can only control and 
improve the disease-associated symptoms (Finn, 2017). In 
AD, there is an excessive activity of acetylcholinesterase 
(AChE) enzyme that hydrolyze acetylcholine, a potential 
neurotransmitter in cholinergic neurons of the cerebral 
cortex part of the brain, leading to acetylcholine deficiency, 
choline accumulation and loss of memory (Quirion, 1993; iD
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Greenblatt et al., 1999). Therefore, current medicines for 
AD symptoms are essentially acetylcholinesterase inhibitors 
such as donepezil and galantamine that act by preventing the 
excessive AChE-catalyzed hydrolysis of acetylcholine and 
thereby improving cognitive symptoms (Ali et al., 2013). 
In addition, oxidative stress resulting from free radicals has 
been implicated in the pathogenesis of neurodegenerative 
diseases including AD (Omar et al., 1999; Mariani et al., 
2005). Therefore, many antioxidant compounds have been 
very useful in neuroprotection against AD (Finn, 2017). 
There are many raw plant extracts/herbal formulations with 
immense uses as natural remedies in the treatment of AD 
and other neurodegenerative diseases. Many traditional 
natural medical systems have various brain tonics and 
memory enhancers (Perry et al., 1999).
In the present study, some chemical constituents such 
as lipids and some phenolics were isolated and identified 
in addition to the acetylcholinesterase inhibitors and 




The aerial parts of P. atropurpureus was collected in 
June 2015 from botanical garden, Faculty of Agriculture, 
Cairo University and kindly identified by Dr. Mohammed 
Elgebaly at Phytochemistry and Plant Systematic Dept., 
National Research Center (NRC). Voucher specimen 
was deposited at the herbarium of the NRC (Herbarium 
specimen number: 11501).
Extraction of lipid and phenolic constituents
About 1.5 kg of the air dried powdered plant material 
of P. atropurpureus were extracted with hexane in a Soxhlet 
for two days. The hexane extract was passed over Fuller’s 
earth to remove the colored pigments and evaporated 
in vacuo to give a yellowish residue (6.5 g), which was 
dissolved in hot acetone to afford two fractions, acetone 
insoluble fraction which was filtered and analyzed by 
Gas chromatography-Mass spectrometry (GC/MS) and 
acetone soluble fraction which subjected to saponification 
process to afford the unsaponifiable materials and fatty 
acid methyl esters fraction which were identified using 
Gas liquid chromatography (GLC) (Gören et al., 2003). 
The defatted plant material (1400 g) was divided into two 
portions (700 g each), the first portion was extracted with 
methanol: chloroform mixture (50:50) for two days, filtered 
and the precipitated material during the concentration was 
separated and washed with chloroform to afford a dark 
brown precipitate and chloroform/methanol extract. The 
second portion was macerated in aqueous methanol (70%) 
for five days to produce a brownish extract, concentrated up 
to 700 mL which increased to 1000 mL with hot distilled 
water, the precipitated material was filtered off and the filtrate 
was partitioned with successive portions of chloroform, 
ethyl acetate and butanol. The butanol fraction was applied 
into a Polyamide column (5x75) eluted with 100% water, 
water/methanol gradients and decreasing the polarity by 
increasing the amount of methanol up to methanol 100%. 
The different fractions which contain the main compounds 
were further purified using small columns of Polyamide and 
Sephadex LH-20 to afford three compounds (PA-І, PA-П 
and PA- III). The ethyl acetate fraction (about1.5 g) was 
dissolved in methanol and subjected to preparative paper 
chromatography, developed with AcOH (20%). Two main 
bands were localized, cut off and eluted with hot methanol 
to afford two main compounds which were further purified 
by passing through Sephadex LH-20 column eluted with 
methnol (95%) to afford compounds PA-IV and PA-V.
Gas liquid chromatography (GLC) analysis of 
unsaponifiable matters
The GLC analyses were carried out using the GC 
instrument, Varian model 3700. The GC was equipped 
with capillary column (AG-Bp-70). Polysilphenylene-
siloxane, 60 m length, 320 µmL internal diameter, 
0.25 µmL film thickness. Analyses were carried out 
using the following temperature program: 70 °C, rising at 
4 °C/min to 270 °C and the injector and detector were held 
at 280 °C and 290 °C, respectively. Flow rates of N2 and 
H2 30 mL/min and Air 300 mL/min.
Gas liquid chromatography (GLC) analysis of fatty 
acid methyl esters (FAMEs)
The GLC analyses were carried out using the GC 
instrument, Varian model 3700. The GC was equipped with 
capillary column (AG-Bp-70). Polysilphenylene-siloxane, 
60 m length, 320 µmL internal diameter, 0.25  µmL film 
thickness. Analyses were carried out using the following 
temperature program: 70 °C, rising at 4 °C/in to 190 °C 
and the injector and detector were held at 240 °C and 
280 °C, respectively. Flow rates of N2 and H2 30 mL/min, 
Air 300 mL/min.
AChE Inhibitory activity
The AChE inhibitory activity of each extract was 
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tested using 96-well micro-plate assay based on previously 
published methods (Ingkaninan et al., 2000; Rhee et al., 
2001) with minor modifications. Each extract (25 μL of 
10× of final concentrations in DMSO) was dispensed in 
duplicates onto 96 well microplate and mixed with 200 μl of 
Ellman’s mixture [final concentrations of 10 mM Tris–HCl, 
pH 8.0, 0.1% bovine serum albumin (BSA, fraction V), 
1.5 mM acetylthiocholine iodide (ATCI, Carbosynth, UK) 
and 150 μM 5,5’- dithio-bis-(2-nitrobenzoic acid), DTNB, 
Sigma-Aldrich, Germany]. The control wells contained the 
extract vehicle (DMSO) instead of the extract. The reaction 
was started with the addition of AChE enzyme solution 
(0.02 U/mL, type VS –from electric eel, Sigma-Aldrich, 
Germany). Non-enzymatic autohydrolysis of the substrate 
was corrected by replacing the enzyme with 25 µl of enzyme 
buffer (50 mM Tris–HCl, pH 8, 0.1% BSA) in duplicate 
wells. The enzymatic activity was monitored kinetically 
at 405 nm in a microplate reader (Zenyth 200, Biochrom® 
Anthos, Cambridge, UK), every 20s intervals for 20 cycles. 
The enzyme rate was calculated from the slope of the 
curve of absorbance change vs. time. Neostigmine methyl 
sulphate (0-31.25 μg/mL) was used as reference AChE 
inhibitor. As screening strategy, final concentration of 
50 μg/mL from each extract was examined and the average 
% inhibition was calculated relative to the enzyme rate of 
the vehicle control wells according to the equation: 
 
Microwell assay of DPPH radical scavenging
Extracts were prepared in DMSO as 10x stocks 
from each test concentration and briefly sonicated when 
necessary in an ultrasonic water bath. In a preliminary 
screen, extracts that produced radical scavenging activities 
≥ 50% at 100 µg/mL were taken for further concentration-
response testing to determine the EC50 (concentration of 
the extract producing 50% scavenging of the DPPH). 
Quercetin dihydrate was used as reference antioxidant. 
The method used in the present study was based on 
previously published methods (Braca et al., 2001; Nara et 
al., 2006). The extract stock solutions (20 µL/well) were 
pipetted in triplicate onto 96-well plates (flat-bottomed, 
Grene Bio-one, Germany). The assay was started with 
the addition of DPPH reagent (0.004% wt/v in methanol, 
180 µl /well). Appropriate blanks were prepared using 
the solvent only in addition to the same amount of DPPH 
reagent to get rid of any inherent solvent activity. Negative 
controls were run in parallel to correct for sample color 
by OD subtraction. The plate was incubated in dark for 30 
min at room temperature and then absorbances were read 
on a Zenyth 200 microplate reader (Biochrom® Anthos, 
Cambridge, UK).
The percentage of antioxidant activity (% AA) was 
calculated using the following equation:
EC50 values (concentrations that scavenge 50% 
of the DPPH in the vehicle control) were derived using 
non-linear regression analysis of the concentration-% 
DPPH scavenging plot on GraphPad Prism® V6.0 (San 
Diego, USA). Data were presented as means ± S.E of three 
experiments.
RESULTS AND DISCUSSION
Identification of lipoidal matter
The lipid constituents of the aerial parts of P. 
atropurpureus were extracted with hexane (Table I-III) and 
fractionated to acetone insoluble fraction, unsaponifiable 
matter and fatty acid methyl esters. The acetone insoluble 
fraction was analyzed using Gas chromatography-Mass 
spectrometry (GC/MS) (Table I) and it was found to 
contain fatty alcohols and hydrocarbons with n-eicosane 
is the main hydrocarbon while octadecanol is the main 
fatty alcohol.
The data in Table II proved that the fatty acid fraction 
was found to consist of eight acids, three of them were 
unsaturated (73.38%) in which linolenic acid the main 
one (48.19%) and five acids are saturated (26.62%) with 
palmitic acid as major (17.90%). These findings were in 
agreement with that reported by Rao, Sino (1992), where 
they found that linolenic acid was the major component 
in P. calycinus.
The Gas liquid chromatography (GLC) analysis 
of the unsaponifiable fraction (Table III) revealed the 
presence of n-hydrocarbons mixture (66.76%) in which 
n-heptacosane (C27) is the main (28.81%), a sterol fraction 
(26.10%) contain three components [campasterol, 
stigmasterol (14.22%) and β-sitosterol] and α-amyrin 
(4.45%) as a triterpene. These data were in agreement with 
that reported by Subraya, Satyanarayana, Yamini (2013), 
where they isolated β-sitosterol, stigmasterol and α-amyrin 
acetate from aerial part of P. lawii.
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Identification of flavonoidal components
The flavonoidal constituents were isolated from the 
butanol and ethyl acetate fractions using different columns 
chromatography as follow:
Compound PA-I
Luteolin-7-O-glucoside: It was obtained as 
yellowish powder, appeared as a brown spot turned yellow 
on spraying with AlCl3 under UV light and it’s behavior 
on paper chromatography proved it’s glycosidic nature. 
The UV spectra in methanol and shifts reagents showed 
that it is a flavone type with occupation at C-7, with an 
ortho-dihydroxy system in ring B. UV spectrum of the 
aglycone of NaOAc/H3BO3 relative to methanol spectrum 
confirmed the presence of a free OH group at C-3´ and 
C-4´. The presence of free OH group at C-5 is confirmed 
by the bathochroic shift of band-1 with AlCl3 relative 
to methanol. The absence of free OH group at C-7 was 
confirmed through NaOAc spectrum (Mabry, Markham, 
Thomas, 1970). The EI-MS displayed M+ at m/z = 448 
which fit to the formula C21H20O11. Another important 
fragments at m/z = 420 and 286 are due to M+- CO and 
hexose moiety respectively. The 1H NMR (400 MHz , 
TABLE I - GC/MS analysis of acetone insoluble fraction of Phyllanthus atropurpureus
Peak No. Rt (min.) % Mol. formula Mol. Wt. Compounds
1 20.92 9.54 C16H34O 242 hexadecanol
2 25.57 15.87 C18H38O 270 octdecanol
3 30.50 2.50 C20H42 282 9-methylnonadecane
4 32.60 44.16 C20H42 282 eicosane
5 37.67 9.67 C27H46 O 386 cholesterol
6 40.57 15.50 C25H52 352 pentacosane
7 ----- 2.76 ----- ----- unknowns
TABLE II - GLC analysis of FAME fraction of Phyllanthus atropurpureus
Peak No. Rt (min.) Rel. % Mol. formula Mol. Wt.     Compounds
1 9.47 1.20 C12H24O2 200 Lauric acid , n-C12:0
2 10.47 1.93 C13H26O2 214 Traidecanoic acid , n-C13:0
3 11.95 3.61 C14H28O2 228 Myristic acid , n-C14:0
4 14.77 17.90 C16H32O2 256 Palmetic acid , n-C16:0
5 17.85 1.98 C18H36O2 284 Stearic acid , n-C18:0
6 18.35 7.89 C18H34O2 282 Oleic acid , n-C18:1
7 19.36 17.30 C18H32O2 280 Linoleic acid, n-C18:2
8 20.62 48.19 C18H30O2 278 Linolenic acid, n-C18:3
TABLE III - GLC analysis of the unsaponifiable fraction of 
Phyllanthus atropurpureus
Peak No. Rt (min) %     Compounds
1 11.4 21.58 n- tetradecane (C14)
2 12.5 0.9 n-pentadecane (C15)
3 15.2 0.9 n-heptadecane (C17)
4 18.7 0.9 n-cosane (C20)
5 19.8 1.22 n-hencosane (C21)
6 20.8 1.67 n-dodacosane (C22)
7 21.8 2.22 n-triacosane (C23)
8 22.8 3.11 n-tetracosane (C24)
9 23.4 2.34 n-pentacosane (C25)
10 24.6 1.33 n-hexacosane (C26)
11 25.8 28.81 n-heptacosane (C27)
12 28.6 1.78 n-nonacosane (C29)
13 31.9 7.45 Campasterol
14 32.5 14.22 Stigmasterol
15 33.4 4.45 β-sitosterol
16 36.4 4.45 α-amyrin
Acetylcholinesterase inhibition, antioxidant and identification of some chemical constituents of Phyllanthus atropurpureus cultivated in Egypt
Braz. J. Pharm. Sci. 2019;55:e18083 Page 5 / 8
DMSO) gave signals at: 7.56 (1H, dd, J=7.6, 1.842, H-6’), 
6.93 (d, J=2.5, H-2’), 6.92 (1H, d, J=7.5, H-5’), 6.24 (s, 
H-3), 6.16 (d, J=2.0 Hz, H-6), 6.28 (d, J=2.0 Hz, H-8), 
5.45 (1H, d, J=7.5, H-1”), 3.35-2.75 (as complex m, rest of 
glucose protons). The acid hydrolysis proved the presence 
of glucose as a sugar and luteolin as an aglycone. And the 
UV spectra of the aglycone proved the presence of the 
glucose moiety at C-7. So, the structure of compound PA-I 
could be elucidated as luteolin 7-O-glucoside (Giannasi, 
1988; Harborne, Baxter, 1999; Saxena, Aprajita, 2008).
Compound PA-II
Kaempferol 3-O-(p-coumaroylglucoside): The 
compound was isolated from the butanol fraction as a 
yellowish powder and it is a glycosidic in nature through 
its chromatographic behavior in different solvent system 
(Rf 0.77 in BAW and 0.34 in 15% AcOH). It is a flavonol 
type of kaempferol structure occupied at C-3 where it’s 
UV spectrum in MeOH gave band-I at 359, also the 
spectrum of the NaOMe reagent proved the presence of 
a free OH groups at C-4’. The C-7 contain a free OH due 
to the bathochromic shift in band-II relative to methanol 
in NaOAc spectrum. The EI MS showed a molecular ion 
peak at m/z 594 and a fragmentation of 285 [kaempferol-H] 
due to the loss of a coumaroyl-glucoside moiety (-308), 
in addition to fragment ions at 447 [M-coumaroyl] and at 
m/z 307 [M-kaempferol]. The 1H-nmr spectrum displayed 
signals at δ in ppm at 7.9 (2H, d, J=8.7 Hz, H-2’,6’), 6.92 
(2H, d, J=8.95 Hz, H-3’,5’), 6.1 (1H, d, J=2.1 Hz, H-6) 
and 6.15 (1H, d, J=1.75 Hz, H-8). The p-coumaric acid 
at 7.5 (2H, d, J=8.8 Hz, H-2’’,6’’), 6.7 (2H, d, J=8.9 Hz, 
H-3’’,5’’), 6.75 (1H, d, J=10.7 Hz, H-7’) and 5.69 (1H, 
d, J=11.2 Hz, H-8’), while the anomeric proton of the 
glucose moiety appeared at 5.2 as (1H, d, J=6.7 Hz). The 
acid hydrolysis revealed the presence of keampferol as an 
aglycone with glucose and p-coumaric acid with aid of 
paper chromatography and authentic samples. All these 
data were agree with that reported and supported the 
identification of compound PA-II as kaempferol 3-O-(p-
coumaroylglucoside) (Felipe et al., 2014).
Compound PA-III
Kaempferitrin: The compound was isolated as a dark 
yellow powder and it is a glycosidic in nature where it’s 
Rf is 0.68 in AcOH (15%) and a flavonol type structure 
where it displayed band-I at 350 nm with free OH group at 
C-4’ where band-I was shifted to 415 nm with increasing 
in intensity. The absence of an ortho dihydroxy system 
was confirmed through both AlCl3/HCl spectrum where 
there is no hypsochromic shift in band-I relative to AlCl3, 
and no bathochromic shift in band -1 in NaOAc/H3BO3 
spectrum relative to methanol, also no free OH groups at 
C-3 and C-7. No bathochromic shift in band –II in NaOAc 
spectrum relative to methanol spectrum which indicates 
no free OH group at C-7. The 1H-nmr (DMSO) gave 
signals at δ in ppm at 7.9 (2H, d, J=8.7 Hz, H-2’, 6’), 6.95 
(2H, d, J=8.3 Hz, H-3’, 5’), 6.81 (1H, d, J=2.35 Hz, H 8), 
6.52 (1H, d, J=2.35 Hz, H-6), the anomeric protons of 
two sugar moieties at 5.54 (1H, d, J=1.3 Hz, H-1’’’), 5.42 
(1H, d, J=1.3 Hz, H-1’’), while the two methyl protons at 
1.05 (3H, d, J=6.32 Hz, H-6’’’), 0.83 (3H, d, J=6.32 Hz, 
H-6’’), finally complex multiplet signals at 3.69-4.31 for 
the rest of the sugar protons. The mass spectrum exhibited 
the molecular ion peak M+ at m/z =579 which correspond 
to the molecular formula C27H30O14. Other peaks at 433 
and 286 confirmed the presence of two deoxy hexose 
moieties. The acid hydrolysis proved the presence of 
kaempferol as an aglycone which confirmed through it’s 
UV and only rhamnose as sugar which were confirmed 
through the comparison with authentic samples in different 
solvents. Thus all the chromatographic and spectroscopic 
measurements confirmed the structure of compound PA-
III as kaempferitrin (kaempferol-3,7-O-dirhamnoside) 
(Gohara, Elmazar, 1997).
Compound PA-IV and Compound PA-V
These two known compounds were isolated from 
the ethyl acetate fraction and were identified as luteolin 
and kaempferol respectively by comparison of their 
spectral data with the literature (Giannasi, 1988; Harborne, 
Baxter, 1999; Saxena, Aprajita, 2008). According to the 
latest review about Phyllanthus genus reported by Mao et 
al. (2016), luteolin-7-O-glucoside, kaempferol 3-O-(p-
coumaroylglucoside) and kaempferitrin (kaempferol-
3,7-O-dirhamnoside) were isolated from this species for 
the first time while the other isolated flavonoids were 
isolated from other species like P. niruri, P. virgatus and 
P. singampattiana.
Acetylcholinesterase inhibition
The screening of the effect of P. atropurpureus 
extracts and fractions against AChE enzyme activity 
is presented in (Figure 1). The results revealed that the 
chloroform fraction produced the highest inhibition of the 
enzyme activity among other tested samples, recording 
82.5% inhibition at 50 µg/mL. Weak inhibition was 
produced by the rest of samples as shown in Figure 1. To 
determine the IC50 of the chloroform extract, dose-response 
experiment was conducted and revealed a concentration-
dependent inhibition of AChE enzyme. Non-linear 
regression analysis of the concentration- % inhibition plot 
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revealed the IC50 value to be 13.7 µg/mL (Figure 2). The 
IC50 for the reference AChE inhibitor was calculated as 3.3 
μg/mL (Figure 3). The obtained activity of the chloroform 
extract could be attributed to it’s alkaloidal contents which 
are known to cause AChE inhibition (Elgorashi, Stafford, 
Van Staden, 2004; Halldorsdottir, Jaroszewski, Olafsdottir, 
2010; Kulhankova et al., 2013; Dong et al., 2015; Benamar 
et al., 2016). Kaur, Kaur, Sirhindi (2017) stated that P. 
niruri contain alkaloids of neuro-pharmacological activity.
Antioxidant activity
The prescreen of the effect of P. atropurpureus 
extracts and fractions on the scavenging of DPPH 
radical revealed the activity of three fractions, namely 
the precipitate from MeOH extract, BuOH fraction and 
water fraction. Concentration-response experiments 
were conducted to reveal the EC50 values (Figure 4 and 
Table IV). The obtained EC50 revealed the most potent FIGURE 1 - Effect of of P. atropurpureus extracts and fractions on AChE enzyme activity. Sample key is 1= Ppt. from 70% 
MeOH extract, 2= BuOH fraction, 3= Water fraction, 4= Mother 
liquor of 70% MeOH extract, 5=70% MeOH extract, 6= CHCl3 
fraction.
FIGURE 2 - Concentration-dependent effect of P. atropurpureus 
chloroform fraction on AChE enzyme Inhibition. IC50 of the 
inhibition was derived using non-linear regression analysis on 
GraphPad Prism V6.0.
FIGURE 3 - Concentration-dependent effect of the reference 
AChE inhibitor neostigmine methyl sulphate on AChE enzyme 
Inhibition. IC50 of the inhibition was derived using non-linear 
regression analysis on GraphPad Prism V6.0.
FIGURE 4 - Concentration-response plots of DPPH radical 
scavenging by different extracts from P. atropurpureus. Samples 
were tested for DPPH radical scavenging as described in the 
methods section. Data are means of three experiments each run 
in triplicate.
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extracts to be the precipitate from MeOH extract, recording 
EC50 value of 21.4 µg/mL which may be attributed to it’s 
phenolic content (Kaur, Kaur, Sirhindi, 2017). In addition 
The BuOH and water fractions exhibited similar pattern of 
concentration-response recording EC50 values of 47.5 and 
51.5 µg/mL, respectively. Further investigation is needed 
to isolate the active constituents of the precipitate from 
MeOH extract through activity-guided isolation.
CONCLUSION
This study resulted in isolation and identification 
of lipid constituents (fatty alcohols, fatty acids and 
unsaponifiable matters), and the flavonoidal compounds 
(aglycone and glycosides). Evaluation of different extracts 
and fractions as acetylcholineesterase inhibitors proved 
that the chloroform fraction is the most active one, while 
the precipitate from MeOH extract exhibited the highest 
antioxidant activity. 
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